CCN2 and myelodysplastic syndrome: Higher mRNA levels of TGF-β and CCN2 have been demonstrated in BM of myelodysplastic syndrome (MDS) with fibrosis than in MDS without fibrosis (Hussein et al. 2018), suggesting a role for both in its pathophysiology.